• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

1995 Fiscal Year Final Research Report Summary

Pharmaceutical Research on Antisense Origonucleotide

Research Project

Project/Area Number 06672150
Research Category

Grant-in-Aid for General Scientific Research (C)

Allocation TypeSingle-year Grants
Research Field Physical pharmacy
Research InstitutionNagoya City University

Principal Investigator

YOTSUYANAGI Tosihisa  Nagoya City university, Pharmaceutical Science, Professor, 薬学部, 教授 (40080189)

Co-Investigator(Kenkyū-buntansha) HAZEMOTO Norio  Nagoya City University, Pharmaceutical Science, Associate Professor, 薬学部, 助教授 (40192273)
Project Period (FY) 1994 – 1995
KeywordsAntisense / Oligonucleotide / Cationic liposome / Suppression of Gene Expression / Cellulor uptake / DNA-liposome Complex
Research Abstract

Cationic liposomes were explored as non-viral vectors for which six cholesterol derivatives with various tertiary amines were newly synthesized as a lipid component. Cationic liposomes consisting of dioleoylphosphatidylethanolamine (DOPE) and the cholesterol derivatives were tested in terms of the frequency of transfection of plasmid pSV2 cat and the suppressing effect of the corresponding antisense (5'-GATCCCCCCCTCCAT-3') against the plasmid DNA.The following were clarified : (1) Fluorescence studies showed that the plasmid DNA forms a relatively large complex with the liposomes at an appropriate ratio (0.15 DNA/lipid, w/w) on these components and excess plasmid DNA lowered the transfection efficiency. (2) Antisense oligonucleotide also formed a large complex with the liposomes, which suppressed the gene expression of the plasmid DNA.(3) The structure of ths complexes formed between plasmid DNA and the liposomes may be different from that formed between the antisense and the liposomes. (4) A confocal microscope study showed that the whole complexes were taken into cells. To establish a new assay system for gene delivery, a human melanoma cell line (A-375-6) to which IL1 is known to stimulate the release of IL6 was selected and the effect of antisense (5'-TGTGGAGAAGGAGTT3') against IL6 was investigated. (1) Cationic liposome enhanced the release of IL6. (2) Antisense suppressed the enhancement by liposome, however, could not depress net release of IL6 stimulated with IL1 from A-375-6.

  • Research Products

    (6 results)

All Other

All Publications (6 results)

  • [Publications] K. Yamamura,T. Sakurai,T. Yotsuyanagi et al: "Sustained Release of Basic Fibroblast Growth Factor from the Synthetic Vascular Prothesis using Hydroxy propyl-chitosanAculd." J. Bioned. Mater. Res. 29. 203-206 (1995)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] H. Takeyama,T. Yotsuyanagi,I. Mizuno et al: "Antitumor Effect of Liposone-Entrapped Carboplatin(Lipo-CBDCA)after Interperitoneal Administration in Rats and a case study" Ist. Int. Gastric Cancer Cong.1587-1592 (1995)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] N. Hazemoto,M. Kobayashi,M. Nagao,T. Yotsuyanagi: "Interaction of plasmid DNA with polypeptide and DNA Transfection Activity" Proceedings of the 22nd International Symposium on Controlled Release of Bioactive Materials. 428-429 (1995)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] N.Hazamoto, M.Kobayashi, M.Nagao, T.Yotsuyanagi: "Interaction of Plasmid DNA with polypeptide and DNA transfection Activity" Proceeding of the 22nd Internatinal Symposium on Controlled Release of Bioactive Materials. 1587-1592 (1995)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] K.Yamamura, T.Sakurai, K.Yano, T.Nabeshima, and T.Yotuyanagi: "Sustained Release of Basic Fibroblast Growth Factor from the Synthetic Vascular Prothesis using Hydoroxypropylchitosan Acetate" J.Biomed.Mater.Res. 29. 203-206 (1995)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] H.Takeyama, T.Yotsuyanagi, I.Mizuno, T.Yasui, M.Ishikawa, Y.Akamo, K.Kobayashi, N.Mohri, J.Terada, M.Nagata and T.Manabe: "Antitumar Effect of Liposome-Entrapped Carboplatin (Lipo-CBDCA) after Intraperitoneal Administration in Rats and a Case Study" Ist.Int.Gastric Cancer Cong.1587-1592 (1995)

    • Description
      「研究成果報告書概要(欧文)」より

URL: 

Published: 1997-03-04  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi